10 Best US Stocks To Buy For 2014

NEW YORK (TheStreet) -- Netflix (NFLX) surpassed Google's (GOOG) YouTube as the top online video service for the first time in three years.

According to a survey of 1,000 online users done by RBC Capital Markets, 44% used Netflix to watch television programs and movies, compared to 43% for YouTube. Last year the numbers were 37% and 40% in favor of YouTube.

Must Read: Warren Buffett's 10 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Streaming service competitor Hulu was a distant third at 27%, down from 28% last year. Amazon Plus (AMZN), while coming in fourth with 22%, saw an increase from last year's 15% mark.

In conjunction with a larger market share in the U.S., RBC's U.K. survey -- which polled 1,500 users -- shows that the video streaming service continues to be popular across the pond. Some 22% of respondents are using the service, compared to 15% for U.K. competitor LOVEFilm.

In the report published Sunday, RBC's Mark Mahaney had high hopes for the future of Netflix, saying "Our key survey findings support the conclusion that Netflix offers an increasingly compelling consumer value proposition in the U.S."

"We continue to believe that Netflix has achieved (a) level of sustainable scale, growth, and profitability that isn't currently factored into its stock price. Netflix is on track to become an Internet video utility."

Netflix closed Monday's trading session down 1.88% at $439.95, but is up 0.10% in after-hours trading.

----------

Seperately, TheStreet Ratings team rates NETFLIX INC as a Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation:

Top 10 Sliver Stocks To Buy For 2015: CVS Corporation(CVS)

CVS Caremark Corporation operates as a pharmacy services company in the United States. The company?s Pharmacy Services segment provides a range of pharmacy benefit management services, including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management, and claims processing; and drug benefits to eligible beneficiaries under the Federal Government?s Medicare Part D program. This segment primarily serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals. As of December 31, 2010, it operated 44 retail specialty pharmacy stores, 18 specialty mail order pharmacies, and 4 mail service pharmacies located in 25 states, Puerto Rico, and the District of Columbia. This segment operates business under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, CarePlus, RxAmerica, Accordant, and TheraCom names. The company?s Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, seasonal merchandise, greeting cards, and convenience foods through its pharmacy retail stores and online, as well as offers film and photo finishing, and health care services. This segment operated 7,182 retail drugstores located in 41 states, Puerto Rico, and the District of Columbia; and 560 retail health care clinics in 26 states and the District of Columbia under the MinuteClinic name. It has a strategic alliance with Alere, L.L.C. for the management of disease management program offerings that cover chronic diseases, such as asthma, diabetes, congestive heart failure, and coronary artery disease. CVS Caremark Corporation was founded in 1892 and is based in Woonsocket, Rhode Island.

Advisors' Opinion:

• [By Grace L. Williams]

  CVS Caremark (CVS) has found the perfect prescription for stock market gains after reporting earnings results this morning.

  Associated Press

  For the quarter ended Dec. 31, CVS reported adjusted EPS of $1.12, up from 96 cents a year ago and ahead of analyst expectations of $1.11. Revenue rose to $32.8 billion from $31.4 a year prior and forecasts for sales of $32.6 billion. CVS also disclosed that it opened 60 new retail drugstores and closed one during the period.

  Last week, CVS made headlines on the announcement that it would end tobacco sales and the market reacted accordingly. In a Barron�� Take, Teresa Rivas wrote, ��ith the number of U.S. smokers on the decline and regulation on the rise, CVS will likely more than make up for lost sales with public goodwill and a boost to its health-care brand. It also gets first mover advantage on a ban that may eventually have been forced on it.��/p>

  Raymond James analyst John Ransom notes that CVS has a healthy future:

  First-quarter 2014 adjusted EPS guidance was actually raised to $1.03-$1.06 (up seven cents at the midpoint), suggesting better-than-expected near-term trends versus prior outlook. Net-net, fourth quarter capped another solid year out of CVS, with today�� stock price reaction likely less tied to the report itself and more focused on the…tobacco headwind offsets as well as initial comments with regard to the 2015 selling season and the retail competitive landscape (promotional activity high?).

  Shares of CVS have advanced 2.7% to $68.74 at 3:0 p.m., trailing Walgreen’s (WAG) 5.3% rise to $63.87 but besting Rite Aid’s (RAD) 1.5% gain to $5.72.

• [By gurujx]

  CVS Caremark Corp (CVS) Reached the 52-Week High of $66.96

  CVS Caremark Corp has a market cap of $79.7 billion; its shares were traded at around $66.96 with a P/E ratio of 18.60 and P/S ratio of 0.66. The dividend yield of CVS Caremark Corp stocks is 1.34%. CVS Caremark Corp had an annual average earnings growth of 13.50% over the past 10 years. GuruFocus rated CvS Caremark Corp the business predictability rank of 4-star.

10 Best US Stocks To Buy For 2014: Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund (ETO)

Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund (the Fund) is a closed-end management investment company. The Fund's investment objective is to provide a high level of after-tax total return. The Fund pursues its objective by investing primarily in dividend-paying common and preferred stocks.

The Fund�� top 10 equity holdings include Freeport-McMoran Copper, Veolia Environment, Southern Copper Corp., Societe Generale, Chevron Corp., Occidental Petroleum Corp., Exelon Corp., Total SA Spon ADR, Entergy Corp. and Suncor Energy Inc. Top 10 equity holdings represented 25.3% of total investments as of April 30, 2007.

Advisors' Opinion:

• [By GURUFOCUS]

  Special Purpose Funds- Eaton Vance Tax-Adv. Global Dividend Oppor. Fund (ETO) | Yield: 7.3%
  - The Gabelli Global Utility & Income Trust (GLU) | Yield: 6.2%
  - Pimco Global Stocksplus Income Fund (PGP) | Yield: 9.5%
  - LMP Real Estate Income Fund Inc. (RIT) | Yield: 7.0%

10 Best US Stocks To Buy For 2014: Agilent Technologies Inc (A)

Agilent Technologies, Inc. (Agilent), incorporated on May 5, 1999, is a measurement company providing bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries. During the fiscal year ended October 31, 2011 (fiscal 2011), it had three business segments: electronic measurement business, chemical analysis business and life sciences business. Its electronic measurement business addresses the communications, electronics and other industries. Agilent�� chemical analysis business focuses on the petrochemical, environmental, forensics and food safety industries. Its life sciences business focuses on the pharmaceutical, biotechnology, academic and Government, bio-agriculture and food safety industries. In addition to its three businesses, it conducts research through Agilent Technologies Laboratories (Agilent Labs). In fiscal 2011, the Company acquired A2 Technologies, Lab901 and Biocius Life Sciences Inc. On December 21, 2011, the Company acquired BioSystem Development business and P.V.R. s.r.l., a vacuum pump manufacturer. In February 2012, the Company acquired software solutions and technology for device-level modeling and validation from Accelicon Technologies. In June 2012, the Company acquired cancer diagnostics company, Dako. In August 2012, the Company acquired Aurora SFC Systems, Inc.

Electronic Measurement Business

The Company�� electronic measurement business provides electronic measurement instruments and systems, software design tools and related services that are used in the design, development, manufacture, installation, deployment and operation of electronics equipment, and microscopy products. Related services include start-up assistance, instrument productivity and application services and instrument calibration and repair. It also offers customization, consulting and optimization services throughout the customer's product lifecycle. It sells products and services applicable to a rang! e of communications networks and systems, including wireless communications and microwave networks, voice, broadband, data, and fiber optic networks. Test products include Electronic Design Automation (EDA) software, vector and signal analyzers, signal generators, vector network analyzers, one box testers, oscilloscopes, logic and protocol analyzers, and bit-error ratio testers.

The Company�� wireless communications and microwave network products include radio frequency and microwave test instruments and electronic design automation software tools. These products are required for the design and production of wireless network products, communications links, cellular handsets and base stations. It provides handheld products for the installation and maintenance of wireless networks. Its electronic design automation software tools and instruments are used by radio frequency integrated circuit design engineers to model, simulate and analyze communications product designs at the circuit and system levels.

The Company�� suite of fiber optic test products measure and analyze a range of optical and electrical parameters in fiber optic networks and their components. Components which can be tested with Agilent solutions include source lasers, optical amplifiers, filters and other passive components. Test products include optical component analyzers, optical power meters and optical spectrum analyzers. It sells the products into the general purpose test market, including general purpose instruments, modular instruments and test software, digital test products, semiconductor and board test solutions, electronics manufacturing test equipment, atomic force microscopes and radio frequency and network surveillance solutions. The Company�� general purpose products include spectrum analyzers, network analyzers, signal generators, logic analyzers, digitizing oscilloscopes, voltmeters, multimeters, frequency counters, bench and system power supplies, function generators and waveform synthesizers. Modular! instrume! nts and test software are used by the designers and manufacturers of electronic devices as the building blocks of systems that can be configured for a range of test applications.

The Company�� digital test products are used by research and development engineers across a range of industries to validate the function and performance of their digital product and system designs. These designs include a range of products from digital control circuits to high speed systems, such as computer servers and the gaming consoles. The test products offered include oscilloscopes, logic and serial protocol analyzers, logic-signal sources and data generators.

The Company�� semiconductor and board test solutions enable customers to develop and test semiconductors, test and inspect printed circuit boards, perform functional testing, and measure position and distance information to the sub-nanometer level. It is a supplier of parametric test instruments and systems used to examine semiconductor wafers during the manufacturing process. Its in-circuit test system helps identify quality defects, such as faulty or incorrect parts, that affect electrical performance. Its laser interferometer measurement systems provide precise position or distance information for dimensional measurements. Its atomic force microscopes (AFM) are imaging devices. An AFM allows researchers to observe and manipulate molecular and atomic level features. Its portfolio of AFM products provides customers with tools for a range of nanotechnology applications, including semiconductor, data storage, polymers, materials science and life science studies. The Company�� surveillance systems and subsystems are used by defense and government engineers and technicians to detect, locate and analyze signals of interest. The products offered include receivers for detecting radio frequency signals, probes for detecting wire line signals and software that enables the identification and analysis of these signals. Agilent's electronic measureme! nt custom! ers include contract manufacturers of electronic products, handset manufacturers and network equipment manufacturers who design, develop, manufacture and install network equipment, service providers who implement, maintain and manage communication networks and services, and companies who design, develop, and manufacture semiconductors and semiconductor lithography systems. Its customers use its products to conduct research and development, manufacture, install and maintain radio frequency, microwave frequency, digital, semiconductor, and optical products and systems and conduct nanotechnology research.

The Company competes with Aeroflex Incorporated, Anritsu Corporation, Ansys Corporation, EXFO Electro-Optical Engineering, Inc., National Instruments Corporation, Rohde & Schwartz GmbH & Co. KG, Spirent plc, Danaher Corporation, Bruker Corporation, LeCroy Corporation, Teradyne, Inc., Test Research Inc. and Zygo Corporation.

Chemical Analysis Business

The Company�� chemical analysis business provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and chemical properties of substances and products. Its product categories in chemical analysis include gas chromatography (GC) systems, columns and components; gas chromatography mass spectrometry (GC-MS) systems; inductively coupled plasma mass spectrometry (ICP-MS) instruments; atomic absorption (AA) instruments; inductively coupled plasma optical emission spectrometry (ICP-OES) instruments; software and data systems; vacuum pumps and measurement technologies; services and support for its products. Agilent provides custom or standard analyzers configured for specific chemical analysis applications, such as detailed speciation of a complex hydrocarbon stream, calculation of gas calorific values in the field, or analysis of a new bio-fuel formulation. It also offers related software, accessories and consumable ! products ! for these and other similar instruments. Its MS products incorporate technologies for measuring mass, including single-quadrupole, triple-quadrupole, and ion trap mass spectrometers. It combines its mass spectrometers with other instruments to instruments, such as GC/MS, and ICP-MS. It also offers related software, accessories and consumable products for these and other similar instruments. The Company�� spectroscopy instruments include atomic absorption (AA) spectrometers, inductively coupled plasma-optical emissions spectrometers (ICP-OES), inductively coupled plasma-mass spectrometers (ICP-MS), fluorescence spectrophotometers, ultraviolet-visible (UV-Vis) spectrophotometers, Fourier Transform infrared (FT-IR) spectrophotometers, near-infrared (NIR) spectrophotometers, Raman spectrometers and sample automation products. It also offers related software, accessories and consumable products for these and other similar instruments.

The Company�� vacuum technologies products are used to create, control, measure and test vacuum environments in life science, industrial and scientific applications where clean and vacuum environments are needed. Products include a range of vacuum pumps, including diffusion, turbomolecular and ion getter; intermediate vacuum pumps, including rotary vane, sorption and dry scroll, vacuum instrumentation, including vacuum control instruments, sensor gauges and meters, and vacuum components, including valves, flanges and other mechanical hardware. Its products also include helium mass spectrometry and helium-sensing leak detection instruments used to identify and measure leaks in hermetic or vacuum environments. The Company offers a range of services, including an exchange and rebuild program, assistance with the design and integration of vacuum systems, applications support and training in basic and advanced vacuum technologies. The Company offers a range of consumable products, which support its technology platforms, including sample preparation consumables, suc! h as soli! d phase extraction (SPE) and filtration products, self manufactured GC and LC columns, chemical standards, and instrument replacement parts. Consumable products also include scientific instrument parts and supplies, such as filters and fittings for GC systems; xenon lamps and cuvettes for UV-Vis-NIR, fluorescence, FT-IR and Raman spectroscopy instruments; and graphite furnace tubes, hollow cathode lamps and specialized sample introduction glassware for its AA, ICP-OES and ICP-MS products.

The Company competes with Bruker Corporation, PerkinElmer Inc., Shimadzu Corporation and Thermo Fisher Scientific Inc.

Life Sciences Business

The Company�� life sciences business provides application-focused technologies and solutions, which include instruments, software, consumables and services. Its product categories include liquid chromatography, mass spectrometry, microarrays, polymerase chain reaction (PCR) instrumentation, bioreagents, electrophoresis, software and informatics, nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) systems, and, consumables and services. The Agilent liquid chromatograph (LC) portfolio is modular in construction and can be configured as analytical and preparative systems. Agilent's liquid chromatography/ mass spectrometer (LC/MS) portfolio includes instruments built around five analyzer types, such as single quadrupole, triple quadrupole, ion trap, time-of-flight (TOF) and quadrupole time-of-flight (QTOF). It is a provider of microarray-based, genomics research solutions. It provides products for sequencing platforms. Its portfolio of PCR instrumentation, reagents and kits, coupled with its other products, such as microarrays and target enrichment systems for sequencing, provides a range of workflow solutions to customers in the genomics marketplace.

Agilent is a supplier of electrophoretic separation solutions. The 2100 Bioanalyzer analyzes biomolecules or cells in microfluidic networks of channels and wells etched i! nto glass! chips. The 3100 OFFGEL Fractionator resolves proteins or peptides by isoelectric point with liquid-phase recovery. It provides software for instrument control, data acquisition, data analysis, laboratory content and business process management, and informatics. With OpenLab, Agilent has open architecture, which enables capture, analyze, and share scientific data throughout the lab and across the enterprise. It offers a range of consumable products, which support its LC, and MS technology platforms. These consumable products include sample preparation products; self manufactured LC columns and instrument replacement parts, and consumable supplies to meet its customers' analysis needs. It offers a range of startup, operational, educational and compliance support services for measurement and data handling systems. Its support services include maintenance, troubleshooting, repair and training for all of its chemical and bioinstrumentation analysis hardware and software products.

The Company competes with Affymetrix Inc., Bruker Corp., Danaher Corporation, Illumina, Inc., Life Technologies Corp., Thermo Fisher Scientific Inc. and Waters Corp.

Advisors' Opinion:

• [By Dr. Zen]

  4. INVESTING CASH WISELY: Is the company using that cash flow in a wise manner? (a) avoiding macho or bleary-eyed acquisitions; (b) reinvesting in research and development, marketing and other critical areas in the company.

• [By Sujan Lahiri]

  (A)

  The first stage is the removal (harvesting) of a sliver of dermal tissue, called a micro-organ (2-3mm diameter x 30-40mm length), from beneath the patient's skin. This procedure is performed under a local anesthetic, is intended to be performed in a physician's office and is minimally invasive, so as to encourage rapid healing with little or no scarring. Generally, more than one micro-organ will be harvested from the patient (typically 4-5).

• [By Benjamin Pimentel]

  The tech sector also got a lift from shares of Agilent Technologies (A) , which were up 8.7% to close at $54.93 after the company reported better-than-expected profit.

• [By Eric Volkman]

  Agilent Technologies (NYSE: A  ) results for the company's Q2 have been released. For the quarter, net revenue was flat on a year-over-year basis at $1.73 billion. Net profit, however, experienced a drop of 35% over that time frame, landing at $166 million ($0.48 per diluted share) from Q2 2012's $255 million ($0.72).

10 Best US Stocks To Buy For 2014: St. Jude Medical Inc.(STJ)

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart to the device. The Cardiovascular segment offers mechanical and tissue replacement heart valves, as well as heart valve repair products. It also pr ovides disposable interventional devices, including vascular closure devices, compression assist devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters, as well as diagnostic coronary imaging technology. The Atrial Fibrillation segment offers a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It provides electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, such as rechargeable implantable pulse generators, primary cell implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.

Advisors' Opinion:

• [By James Brumley]

  In this new era of stingier insurers and pickier patients, the importance of such procedures can’t be overstated.

  Medical Devices: St. Jude Medical (STJ)

  While St. Jude Medical (STJ) might not have a flagship product that turns heads every time it’s mentioned, it more than makes up for a lack of pizzazz with a large library of highly marketable and consistently-selling medical devices. And, jiving with that broad observation is last quarter’s 2.5% improvement in the bottom line, and a 2014 outlook that affirmed the company’s expectation for a return of earnings and revenue growth.

• [By Marc Bastow]

  Cardiovascular medical device designer and manufacturer St. Jude Medical (STJ) raised its quarterly dividend 8% to 27 cents per share, payable April 30 to shareholders of record as of March 31.
  STJ Dividend Yield: 1.60%

• [By Dan Carroll]

  St. Jude Medical (NYSE: STJ  ) has been under fire recently from sales losses in its cardiology divisions, but renal denervation could be a life-saver for this beleaguered company. The firm earned CE Mark approval for its EnligHTN renal denervation system back in 2012, and it launched a clinical study in February to study the system's benefits in preventing conditions such as heart attack or stroke. The EnligHTN isn't approved in the U.S. yet, but St. Jude's European approval puts this company on the fast track to becoming a major player in renal denervation.

• [By Dan Carroll]

  Investors have gotten their money's worth out of Boston Scientific's (NYSE: BSX  ) stock lately. Shares of the medical device maker have surged by more than 30% in the past six months alone, rising higher despite the company's troubles. Sales have fallen into a slump at Boston Scientific, led lower by the company's cardiac rhythm management, or CRM, business, which produces everything from pacemakers to implantable defibrillators. This is an industry on the decline�--�Medtronic (NYSE: MDT  ) , a leader in the medical device field, has seen its own CRM sales slump in recent quarters, while Boston Sci rival St. Jude Medical (NYSE: STJ  ) has similarly had its top line hammered by its CRM division's falling revenue.

10 Best US Stocks To Buy For 2014: Alon USA Energy Inc. (ALJ)

Alon USA Energy, Inc. engages in refining and marketing petroleum products primarily in the South Central, Southwestern, and Western regions of the United States. The company operates in three segments: Refining and Marketing, Asphalt, and Retail. The Refining and Marketing segment refines crude oil into petroleum products, including gasoline, diesel fuel, jet fuel, petrochemicals, feed stocks, asphalts, and other petroleum products. It markets finished products and blend stocks through sales and exchanges with other oil companies, state and federal governmental entities, unbranded wholesale distributors, and various other third parties. This segment also markets motor fuels to distributors under the Alon brand; and licenses Alon brand name and provides payment card processing services, advertising programs, and loyalty and other marketing programs to licensed locations. The Asphalt segment is involved in the marketing of patented tire rubber modified asphalt products; and production of paving and roofing grades of asphalt comprising performance-graded asphalts, emulsions, and cutbacks. This segment sells paving asphalt to road and materials manufacturers and highway construction/maintenance contractors; polymer modified or emulsion asphalt to highway maintenance contractors; and roofing asphalt to roofing shingle manufacturers or other industrial users. The Retail segment operates retail convenience stores that offer various grades of gasoline, diesel fuel, food products, tobacco products, non-alcoholic and alcoholic beverages, and general merchandise primarily under the 7-Eleven and Alon brands. As of December 31, 2012, it had 298 retail convenience stores located in Central and West Texas, and New Mexico. The company was founded in 2000 and is headquartered in Dallas, Texas. Alon USA Energy, Inc. is a subsidiary of Alon Israel Oil Company, Ltd.

Advisors' Opinion:

• [By Rich Smith]

  The Department of Defense issued $1.3 billion worth of new contract awards Friday. However, a single, $950 million award for engineering services accounted for the bulk of the spending -- and that one went to a series of privately held companies. Publicly traded names fared less well. Among the few winners:

• [By Tom Dorsey]

  Over a several day period, I submitted questions and Mr. Eisman, President, Chief Executive Officer and Director of Alon USA Energy Inc. (ALJ) and the parent company of Alon USA Partners LP Inc. (ALDW) responded. He provided some key insights to some challenges the company faces, where the company is going, and the opportunities available in the future. This insight should provide investors with additional information to understand the value of the company and the opportunity as an investor in the company.

• [By Ben Levisohn]

  Alon USA Energy (ALJ) and Alon USA Partners (ALDW) are surging thanks to a Credit Suisse upgrade, even as refiners like Valero Energy (VLO), Phillips 66 (PSX) and Holly Frontier (HFC) stumble.

  Bloomberg News

  Analyst Edward Westlake and team explain their optimism for the Alon USA pair:

  ALDW: Accounting for the revised commodity forecasts (plus support from
  the self-help programs that the company is pursuing), our LT EBITDA rises by c4% on average. Granted that there is the possibility that ALDW will not be able to pay out a distribution in 4Q13/1Q14, we flag that for those willing to look past the near-term headwinds, the rolling 12 month forward potential yield starting in 2Q14 is 15% (and rises to c20% by 4Q14) ��Certainly hard to overlook at these levels.

  ALJ: Accounting for the revised commodity forecasts (plus support from selfhelp
  programs), our LT EBITDA rises by c9% on average. ALJ could be worth up to c$15/sh (including the $2.25/sh expected contribution from the Bakersfield start-up ��Delivery of this project is key). At current levels, the stock still provides c20% upside in the scenario where Bakersfield does not proceed (or c40% if it does). We raise our rating and target price to Neutral and $14/sh.

  Alon USA Energy has gained 11% to $11.34 and Alon USA Partners has risen 5.2% to $11.12, even as Valero Energy has dropped 0.5% to $40.12, Phillips 66 has dipped 0.4% to $65.09 and Holly Frontier has fallen 1.1% to $43.71.

10 Best US Stocks To Buy For 2014: Groupe Eurotunnel SA (GET)

Groupe Eurotunnel SA, (also GET SA), is a France-based company having its expertise in infrastructure management and railway operations. It manages and operates the Channel Tunnel between the United Kingdom and France and its railway infrastructure. The Company is also engaged in passenger and freight transport between continental Europe and the United Kingdom. In addition, it provides ferry transport through the Channel. Groupe Eurotunnel SA has direct and indirect stakes in a number of companies, including The Channel Tunnel Group Limited, France Manche SA, Europorte SAS, Europorte Channel SAS, Europorte Proximite SAS, GB Railfreight Limited, Eurotunelplus GmbH and others. Advisors' Opinion:

• [By Robert Wall]

  At the same time it faces new competition as Deutsche Bahn plans services from Germany to London via the Channel Tunnel from 2016 after a three-year safety study, Groupe Eurotunnel SA (GET), which runs the 30-mile subsea link, said in June.

10 Best US Stocks To Buy For 2014: Cablevision Systems Corporation (CVC)

Cablevision Systems Corporation provides telecommunications and media services. It operates in two segments, Telecommunications Services and Other. The Telecommunications Services segment is involved in television business, including video, high-speed data, and VoIP operations, as well as the provision of commercial data and voice services. The Other segment offers Newsday, a daily newspaper; amNewYork, a free daily newspaper; and Star Community Publishing, a group of weekly shopper publications; and newsday.com and exploreLI.com. This segment also engages in motion picture theatre business, Clearview Cinemas; provision of the News 12 Networks, a regional news programming services; and the MSG Varsity network, a network covering high school sports and activities, and other local programs, as well as cable television advertising. Cablevision Systems Corporation was founded in 1985 and is headquartered in Bethpage, New York.

Advisors' Opinion:

• [By Paul Ausick]

  SNL Kagan noted that cable outfits like Comcast Corp. (NASDAQ: CMCSA), Time Warner Cable (NYSE: TWC) and Cablevision Corp. (NYSE: CVC) saw subscriber losses double to 607,000. Cable�� share of the pay TV market has now fallen to 55.3%.

• [By WWW.DAILYFINANCE.COM]

  'Interconnection' The better access that Netflix is getting from Comcast is known as "interconnection," a term referring to digital content's journey to an Internet service provider's gates. That path technically isn't covered by the current definition of Net neutrality, which refers to how service providers treat digital content once it's inside the gates. Comcast has promised to honor the previous rules governing Net neutrality through 2018. In a blog post last month, Hastings argued that future Net neutrality guidelines should be expanded to address interconnection issues, too. "Without strong Net neutrality, big ISPs can demand potentially escalating fees for the interconnection required to deliver high quality service," Hastings wrote. "The big ISPs can make these demands -- driving up costs and prices for everyone else -- because of their market position." Google's YouTube video site and many other websites were paying interconnection fees to Comcast before Netflix struck its own deal with the carrier. Even with the March improvements, Comcast's delivery of Netflix content lags behind several other major service providers. Cablevision (CVC), Cox, Suddenlink and Charter (CHTR) each delivered Netflix video at higher speeds than Comcast in March, according to Monday's breakdown. Netflix has interconnection deals with Cablevision, Cox and Suddenlink, although those arrangements don't require Netflix to pay fees.

• [By Jonathan Berr]

  Its doubtful that federal antitrust regulators would ever allow Comcast (CMCSA) to buy the company because some might argue it would restrict competition. The company might be able to acquire Cablevision (CVC) if the Dolan family, which controls the smaller cable company, would sell. But that seems unlikely.

• [By Sean Williams]

  For a second day in a row, we need to look no further than the broadcasting sector for our best performers. Time Warner Cable (NYSE: TWC  ) and Cablevision (NYSE: CVC  ) advanced 8.1% and 3.5%, respectively, on speculation that a wave of mergers and acquisitions would sweep through the sector. If you recall, Gannett�shares soared after announcing a $1.5 billion purchase of Belo�yesterday to expand its national broadcasting presence.